Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients

Bone Marrow Transplantation volume 30, pages 375–380 (2002)Cite this article

Abstract

Graft-versus-host disease (GVHD) is a major complication after hemopoietic stem cell transplantation (HSCT), but its pathogenesis remains uncertain. Macrophage migratory inhibitory factor (MIF) is an important mediator in the allo-immune reaction during renal transplantation, yet its role in hemopoietic stem cell transplantation (HSCT) remains unexplored. This study investigated the potential role of MIF in acute graft-versus-host disease (aGVHD) following allogeneic HSCT. Forty-six randomly selected patients undergoing autologous or allogeneic HSCT were studied. Immunohistochemistry and in situ hybridization were performed to examine tissue MIF mRNA and protein expression on skin and colonic biopsy specimens. The associated T cell and macrophage activation was also studied by immunohistochemical studies. A semi-quantitative method was used to assess MIF staining, as well as T cell and macrophage staining. Serial blood samples were analyzed by ELISA for serum MIF levels. Immunohistochemistry and in situ hybridization performed in 15 skin and 19 colonic biopsies from 17 patients who developed moderate to severe aGVHD showed a significant increase in MIF mRNA and protein expression compared with normal controls (seven skin and five colonic biopsies). MIF was localized within the epidermis and the vascular area of skin, but diffusely expressed in the entire thickness of colon. Macrophage and T lymphocyte infiltration was confined to areas of strong MIF expression. Serial analysis by ELISA showed that only patients who developed aGVHD (n = 19) exhibited an increase (two- to three-fold) in serum MIF during HSCT, but not in the allogeneic HSCT recipients without aGVHD (n = 7) or those who received autologous HSCT (n = 8). In 14 out of 19 patients, serum MIF peaked before the onset of aGVHD. Local and systemic up-regulation of MIF expression is associated with the occurrence of acute GVHD. Its pathogenetic role remains to be further determined.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Krenger W, Hill GR, Ferrara JLM . Cytokine cascades in acute graft-versus-host disease Transplantation 1997 64: 553 558

    Article  CAS  Google Scholar 

  2. Krenger W, Ferrara JLM . Graft-versus-host disease and the Th1/Th2 paradigm Immun Res 1996 15: 50 73

    Article  CAS  Google Scholar 

  3. Williamson E, Garside P, Bradley JA, Mowat AM . IL-12 is a central mediator of acute graft-versus-host disease in mice J Exp Med 1996 188: 1485 1492

    Google Scholar 

  4. Deeg HJ . Graft-versus-host disease: host and donor views Semin Hematol 1993 30: (Suppl. 4) 110 118

    CAS  PubMed  Google Scholar 

  5. David JR . Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction Proc Natl Acad Sci USA 1966 56: 72 77

    Article  CAS  Google Scholar 

  6. Bloom BR, Bennett B . Mechanism of a reaction in vitro associated with delayed-type hypersensitivity Science 1966 153: 80 82

    Article  CAS  Google Scholar 

  7. Nishino T, Bernhagen J, Shiiki H et al. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland Mol Med 1995 1: 781 788

    Article  CAS  Google Scholar 

  8. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature 1993 365: 756 759

    Article  CAS  Google Scholar 

  9. Calandra T, Bernhagen J, Mitchell RA, Bucala R . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 1994 179: 1895 1902

    Article  CAS  Google Scholar 

  10. Bacher M, Metz CN, Calandra T et al. An essential regulatory role for macrophage migration inhibitory factor in T cell activation Proc Natl Acad Sci USA 1996 93: 7849 7854

    Article  CAS  Google Scholar 

  11. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production Nature 1995 377: 68 71

    Article  CAS  Google Scholar 

  12. Lan HY, Yang N, Brown FG et al. Macrophage migration inhibitory factor expression in human renal allograft rejection Transplantation 1998 66: 1465 1471

    Article  CAS  Google Scholar 

  13. Brown FG, Nikolic-Paterson DJ, Metz C et al. Up-regulation of MIF expression in acute renal allograft rejection in the rat Clin Exp Immunol 1999 118: 329 336

    Article  CAS  Google Scholar 

  14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295 304

    Article  CAS  Google Scholar 

  15. Lan HY, Mu W, Yang N et al. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis Am J Pathol 1996 149: 1119 1127

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Lan HY, Yang N, Nikolic-Paterson DJ et al. Expression of macrophage migration inhibitory in human glomerulonephritis Kidney Int 2000 57: 499 509

    Article  CAS  Google Scholar 

  17. Lan HY, Mu W, Nikolin-Paterson DJ, Atkins RC . A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens J Histochem Cytochem 1995 43: 97 102

    Article  CAS  Google Scholar 

  18. Lan HY, Mu W, Ng YY, Nikolic-Paterson DJ, Atkins RC . A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology J Histochem Cytochem 1996 44: 281 287

    Article  CAS  Google Scholar 

  19. Nathan CF, Kamobsky ML, David JR . Alterations of macrophage functions by mediators from lymphocytes J Exp Med 1971 133: 1356 1376

    Article  CAS  Google Scholar 

  20. Nathan CF, Remold HG, David JR . Characterization of a lymphocyte factor which alters macrophage function J Exp Med 1973 137: 275 288

    Article  CAS  Google Scholar 

  21. Bernhagen J, Bacher M, Calandra T et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction J Exp Med 1996 183: 277 282

    Article  CAS  Google Scholar 

  22. Calandra T, Bucala R . Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system Crit Rev Immunol 1997 17: 77 88

    Article  CAS  Google Scholar 

  23. Bernhagen J, Calandra T, Cerami A, Bucala R . Macrophage migration inhibitory factor (MIF) is a neuroendocrine mediator of endotoxemia Trends Microbiol 1994 2: 198 201

    Article  CAS  Google Scholar 

  24. Lan HY, Bacher M, Yang N et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat J Exp Med 1997 85: 1455 1465

    Article  Google Scholar 

  25. Yang N, Nikolic-Paterson DJ, Ng YY et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production Mol Med 1998 4: 413 424

    Article  CAS  Google Scholar 

  26. Atkins RC, Nikolic-Paterson DJ, Bucala R, Lan HY . Macrophage migration inhibitory factor (MIF) – potential perspectives for immune-intervention in renal disease Nephrol Dial Transplant 1998 13: 2719 2720

    Article  CAS  Google Scholar 

  27. Lan HY . Therapeutic effects of cytokine blockade in glomerulonephritis Nephrol Dial Transplant 1998 13: 7 9

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Dr Wong Wai-Man, Mr Wei Mu, Mr Alvin TK Fung and Mr Howard CH Chow for their technical assistance. This study was supported by the Hong Kong Research Grant Council (RGC HKU7325 and 7323), and the Kadoorie Charitable Foundations.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong

    JWS Lo, AYH Leung, XR Huang, AKW Lie, R Liang & HY Lan

  2. The Picower Institute for Medical Research, Manhasset, NY, USA

    C Metz & R Bucala

Authors
  1. JWS Lo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. AYH Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. XR Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AKW Lie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Metz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Bucala
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. HY Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lo, J., Leung, A., Huang, X. et al. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients. Bone Marrow Transplant 30, 375–380 (2002). https://doi.org/10.1038/sj.bmt.1703639

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703639

Keywords

Search

Advanced search

Quick links